Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4542-4549

  Minshall, Christian ^a   Arkins, Sean ^a,c   Dantzer, Robert ^b   Freund, Gregory G ^a   Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c ILLINOIS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INTERLEUKIN 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; SOMATOMEDIN C; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CATALYSIS; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; HEMATOPOIETIC CELL; LIGAND BINDING; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TARGET CELL;

EID: 0033561763     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Toker, A., and L. C. Cantley. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673.
2. Dardevet, D., C. Sornet, T. Vary, and J. Grizard. 1996. Phosphatidylinositol 3-kinase and p70 S6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor-I. Endocrinology 137:4087.
3. Coolican, S. A., D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653.
4. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan, and M. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661.
5. Parrizas, M., A. R. Saltiel, and D. LeRoith. 1997. Insulin-like growth factor-1 inhibits apoptosis using the phosphatidylinosilol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:154.
6. Minshall, C., S. Arkins, G. G. Freund, and K. W. Kelley. 1996. Requirement for phosphatidylinositol 3′-kinase to protect hematopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156:939.
7. Zamorano, J., H. Y. Wang, L. M. Wang, J. H. Pierce, and A. D. Keegan. 1996. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol 157:4926.
8. Zamorano, J., and A. D. Keegan. 1998. Regulation of apoptosis by tyrosine-containing domains of IL-4Rα: Y497 and Y713, but not the STAT-6-docking tyrosines, signal protection from apoptosis. J. Immunol. 161:859.
9. Price, D. J., J. R. Grove, V. Calvo, J. Avruch, and B. E. Bierer. 1992. Rapamycin induced inhibition of the p70 S6 kinase. J. Biol. Chem. 266:16281.
10. Monfar, M., K. P. Lemon, T. C. Grammar, L. Cheatham, J. Chung, C. J. Vlahos, and J. Blenis. 1995. Activation of pp70/85 S6-kinases in interleukin-2 responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 15:326.
11. Yenush, L., R. Fernandez, M. G. Myers, Jr., T. C. Grammer, X. J. Sun, J. Blenis, J. H. Pierce, and M. F. White. 1996. The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis. Mol. Cell. Biol. 16:2509.
12. Myers, M. G., Jr., T. C. Grammar, L. M. Wang, X. J. Sun, J. H. Pierce, J. Blenis, and M. F. White. 1994. Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70 S6-kinase signaling during insulin, insulin-like growth factor-I and interleukin-4 stimulation. J. Biol. Chem. 269:28783.
13. Kanda, S., M. N. Hodgkin, R. J. Woodfield, M. J. Wakelam, G. Thomas, and L. Claesson-Welsh. 1997. Phosphatidylinositol 3′-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cell. J. Biol. Chem. 272:23347.
14. Yao, R., and G. M. Cooper. 1995. Requirement for phosphatidylinositol 3′-kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003.
15. Carpenter, C. L., and L. C. Cantley. 1996. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8:153.
16. Domin, J., R. Dhand, and M. D. Waterfield. 1996. Binding to the platelet-derived growth factor receptor transiently activates the p85α-110α phosphoinositide 3-kinase complex in vivo. J. Biol. Chem. 271:21614.
17. Wang, H. Y., J. Zamarano, J. L. Yoerkie, W. E. Paul, and A. D. Keegan. 1997. The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on Jak-1 expression in fibrosarcoma cells. J. Immunol. 158:1037.
18. Johnston, J. A., L.-M. Wang, E. P. Hanson, X -J. Sun, M. F. White, S. A. Oakes, J. H. Pierce, and J. J. O'Shea. 1995 Interleukins 2,4,7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells: potential role of JAK Kinases. J. Biol. Chem. 270:28527.
19. Thompson, P. A., J. S. Gutkind, K. C. Robbins, J. A. Ledbetter, and J. B. Bolen. 1992. Identification of distinct populations of PI-3 kinase activity following T-cell activation. Oncogene 7:719.
20. Chen, X. H., B. K. R. Patel, L. M. Wang, M. Frankel, N. Ellmore, R. A. Flavell, W. J. LaRochelle, and J. H. Pierce. 1997. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules. J. Biol. Chem. 272:6556.
21. Welham, M. J., H. Bone, M. Levings, L. Learmonth, L.-M. Wang, K. B. Leslie, J. H. Pierce, and J. W. Schrader. 1997. Insulin receptor substrate-2 is the major 170 kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J. Biol. Chem. 272:1377.
22. Myers, M. G., Jr., X.-J. Sun, B. Cheatham, B. R. Jachna, E. M. Glasheen, J. M. Backer, and M. F. White. 1993. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132:1421.
23. Sun, X. J., L. M. Wang, Y. Zhang, L. Yenush, M. G. Myers, Jr., E. Glasheen, W. S. Lane, J. H. Pierce, and M. F. White. 1995. Role of IRS-2 in insulin and cytokine signaling. Nature 377:173.
24. Kooijman R., J. J. Lauf, A. C. Kappers, and G. T. Rijkers. 1995. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes. J. Exp. Med. 182:593.
25. Erhardt, P., and G. M. Cooper. 1996. Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL. J. Biol. Chem. 271:17601.
26. Terada, N., R. A. Franklin, J. J. Lucas, J. Blenis, and E. W. Gelfand. 1993. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p 70 S6 kinase. J. Biol. Chem. 268:12062.
27. SAS Institute, Inc. 1992. SAS/STAT User's Guide, Version 6, Vol. 2, 4th Ed. SAS Institute Inc., Cary, NC.
28. Brown, E. J., P. A. Beal, C. T. Keith, J. Chen, T. B. Shin, and S. L. Schreiber. 1995. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377:441.
29. Powis, G. R., M. M. Berggren, A. Gallegos, R. Abraham, C. Ashendel, L. Zalkow, W. F. Matter, J. Kokge, and G. Grindley. 1994. Wortmannin, a potent and selective inhibitor of phosphatidylinositol 3′-kinase. Cancer Res. 54:2419.
30. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241.
31. Minshall, C., S. Arkins, J. Straza, J. Connors, R. Dantzer, G. G. Freund, and K. W. Kelley. 1997. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. J. Immunol. 159:1225.
32. Fairbairn, L. J., G. J. Cowling, B. M. Reipert, and T. M. Dexter. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823.
33. Baffy, G., T. Miyashita, J. R. Williamson, and J. C. Reed. 1993. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268:6511.
34. Singleton, J. R., V. M. Dixit, and E. L. Feldman. 1996. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271:31791.
35. Yin, C., C. M. Knudson, S. J. Korsmeyer, and T. Van Dyke. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637.
36. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, Y. Yamoto, and O. Silvennoinen. 1995. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13:398.
37. Argetsinger, L. S., G. Norstedt, N. Billestrup, M. F. White, and C. Carter-Su. 1996. Growth hormone, interferon-γ and leukemia inhibitory factor utilized insulin receptor substrate in intracellular signaling. J. Biol. Chem. 271:29415.
38. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T.-I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129.
39. Chinnaiyan, A. M., K. O'Rourke, B. R. Lane, and V. M. Dixit. 1997. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275:1122.
40. Adams, J. M., and S. Cory. 1998. The Bcl-2 family: arbiters of cell survival. Science 281:1322.
41. Ward, S. G., C. H. June, and D. Olive. 1996. PI 3-kinase a pivotal pathway in T-cell activation. Immunol. Today 17:187.
42. Canicio, J., E. Gallardo, I. Illa, X. Testar, M. Palacin, A. Zorzano, and P. Kaliman. 1998. P70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells. Endocrinology 139:5042.
43. Abraham, R. T. 1998. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr. Opin. Immunol. 10:330.
44. Brunn, G. J., J. Williams, C. Sabers, G. Wiederrecht, J. C. Lawrence, and R. T. Abraham. 1996. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 75:5256.
45. Kulik, G., A. Klippel, and M. J. Weber. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595.
46. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13:513.
47. Akbar, A. N., N. J. Borthwick, R. G. Wickremasinghe, P. Panayoitidis, D. Pilling, M. Bofill, S. Krajewski, J. C. Reed, and M. Salmon. 1996. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26:294.
48. Oltvai, A. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609.
49. White, M. F., and C. R. Kahn. 1994. The insulin signaling system. J. Biol. Chem. 269:1.
50. Wang, L.-M., A. D. Keegan, W. Li, G. E. Lienhard, S. Pacini, J. S. Gutkind, M. G. Myers, Jr., X.-J. Sun, M. F. White, S. A. Aaronson, W. E. Paul, and J. H. Pierce. 1993. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90:4032.
51. Wang, L.-M., M. G. Myers, X.-J. Sun, S. A. Aaronson, M. White, and J. H. Pierce. 1993. IRS-1: essential for IL-4 stimulated mitogenesis in hematopoietic cells. Science 261:1591.
52. Minshall, C., Q. Liu, S. Arkins, and K. W. Kelley. 1996. Growth hormone and immunology. In: Growth Hormone in Critical Illness: Research and Clinical Studies. M. H. Torosian, ed. R. G. Landes Company, Austin Texas, pp.159-184.
53. Kooijman, R., E. L. Hooghe-Peters, and R. Hooghe. 1996. Prolactin, growth hormone and insulin-like growth factor I in the immune system. Adv. Immunol. 63:377.